» Authors » Sara Caylor

Sara Caylor

Explore the profile of Sara Caylor including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 204
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kingsmore S, Wright M, Olsen L, Schultz B, Protopsaltis L, Averbuj D, et al.
Am J Hum Genet . 2024 Dec; 111(12):2643-2667. PMID: 39642868
Large prospective clinical trials are underway or planned that examine the clinical utility and cost effectiveness of genome-based newborn screening (gNBS). One gNBS platform, BeginNGS, currently screens 53,575 variants for...
2.
Kingsmore S, Wright M, Smith L, Liang Y, Mowrey W, Protopsaltis L, et al.
Am J Hum Genet . 2024 Dec; 111(12):2618-2642. PMID: 39642867
Genome-sequence-based newborn screening (gNBS) has substantial potential to improve outcomes in hundreds of severe childhood genetic disorders (SCGDs). However, a major impediment to gNBS is imprecision due to variants classified...
3.
Cakici J, Dimmock D, Caylor S, Gaughran M, Clarke C, Triplett C, et al.
Clin Ther . 2023 Jul; 45(8):736-744. PMID: 37429778
Purpose: Diagnostic genomic research has the potential to directly benefit participants. This study sought to identify barriers to equitable enrollment of acutely ill newborns into a diagnostic genomic sequencing research...
4.
Kingsmore S, Smith L, Kunard C, Bainbridge M, Batalov S, Benson W, et al.
Am J Hum Genet . 2023 Jun; 110(6):1017. PMID: 37267897
No abstract available.
5.
Bupp C, Ames E, Arenchild M, Caylor S, Dimmock D, Fakhoury J, et al.
Children (Basel) . 2023 Jan; 10(1). PMID: 36670656
The integration of precision medicine in the care of hospitalized children is ever evolving. However, access to new genomic diagnostics such as rapid whole genome sequencing (rWGS) is hindered by...
6.
Kingsmore S, Smith L, Kunard C, Bainbridge M, Batalov S, Benson W, et al.
Am J Hum Genet . 2022 Aug; 109(9):1605-1619. PMID: 36007526
Newborn screening (NBS) dramatically improves outcomes in severe childhood disorders by treatment before symptom onset. In many genetic diseases, however, outcomes remain poor because NBS has lagged behind drug development....
7.
Dimmock D, Caylor S, Waldman B, Benson W, Ashburner C, Carmichael J, et al.
Am J Hum Genet . 2021 Jun; 108(7):1231-1238. PMID: 34089648
Genetic disorders are a leading contributor to mortality in neonatal and pediatric intensive care units (ICUs). Rapid whole-genome sequencing (rWGS)-based rapid precision medicine (RPM) is an intervention that has demonstrated...
8.
Sweeney N, Nahas S, Chowdhury S, Batalov S, Clark M, Caylor S, et al.
NPJ Genom Med . 2021 May; 6(1):38. PMID: 34039997
No abstract available.
9.
Sweeney N, Nahas S, Chowdhury S, Batalov S, Clark M, Caylor S, et al.
NPJ Genom Med . 2021 May; 6(1):39. PMID: 34039980
No abstract available.
10.
Sweeney N, Nahas S, Chowdhury S, Batalov S, Clark M, Caylor S, et al.
NPJ Genom Med . 2021 Apr; 6(1):29. PMID: 33888711
Congenital heart disease (CHD) is the most common congenital anomaly and a major cause of infant morbidity and mortality. While morbidity and mortality are highest in infants with underlying genetic...